Comparative effectiveness research

Brain Aneurysm Foundation Announces 2023 Research Grants

Retrieved on: 
Thursday, September 21, 2023
Subarachnoid hemorrhage, Bleeding, Therapy, Beth Israel Deaconess Medical Center, Education, Genetics, Prevalence, Blood, Epigenetics, Impact, Aneurysm, Stroke, Policy, Kick, Aortic rupture, Skull, Research, Risk, Brain, Biomarker, Pop, Science, SAH, ZIC3, BAF, Rupture, Robotics, HDAC2, Big data, Biology, Effectiveness, Diagnosis, Ecosystem, Role, Comparative effectiveness research, Health, Headache, Woman, Social media, Disease, Pharmaceutical industry, Mouse, Engagement

HANOVER, Mass., Sept. 21, 2023 /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms, today announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or developing new treatment methods.

Key Points: 
  • Provides Funding for 17 Research Efforts that aim to Address the Underlying Causes of Disease, New Treatment Paradigms and Key Markers of Ruptures and Hemorrhage
    Total Annual Research Funding Eclipses $5 million; BAF Kicks off its Annual Day of Engagement to Support its Mission of Reducing the Prevalence and Impact of Brain Aneurysms
    HANOVER, Mass., Sept. 21, 2023 /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms, today announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or developing new treatment methods.
  • Research grants are a cornerstone of the organization's mission, as it works to fund critical advances at a time where Federal dollars for brain aneurysm research amounts to just over $2 for every person afflicted.
  • A brain aneurysm is a weak, bulging area in an artery in the brain that in some instances can rupture.
  • Women over the age of 55 have a higher risk of brain aneurysm rupture than men and are generally at greater risk.

CHOP Researchers Validate Pediatric "Allergic March" in Largest National Study of its Kind

Retrieved on: 
Tuesday, July 25, 2023
Shellfish, Allergy, Asthma, Eosinophilic esophagitis, Consortium, Prevalence, CHOP, Food allergy, Dermatitis, CER2, Food, Quality of life, Allergic rhinitis, Philadelphia, Atopic dermatitis, Risk, Doctor of Philosophy, EHR, Patient, Division, DOI, Diagnosis, Hospital, Immunology, Research, Comparative effectiveness research, Immunoglobulin E, Bias, Health information management, Peanut, Disease, Children's Hospital of Philadelphia, Nursing, Dentistry, Vaccine, Cochineal, Pediatrics, Child, MD, White

PHILADELPHIA, July 25, 2023 /PRNewswire/ -- In the largest study of its kind, researchers from Children's Hospital of Philadelphia (CHOP) used electronic health record (EHR) data from more than 200,000 pediatric patients to describe patterns of pediatric allergies across the United States, validating a population-level pattern of allergy development known as the "allergic march," in which allergies first present as eczema, followed by food allergies, asthma, and environmental allergies. The researchers also found that a rare food allergy called eosinophilic esophagitis (EoE), which has historically been considered a disease affecting primarily White males, is more common among non-White patients than previously reported.

Key Points: 
  • "Prior studies have gauged the prevalence and patterns of allergies based on surveys completed by families.
  • For each condition, they determined the age at diagnosis and whether and when patients presented with other allergic conditions.
  • The researchers examined demographic trends to examine non-biologic factors that may affect predisposition to allergy.
  • "Patterns of pediatric allergy across a multi-state electronic health record consortium," Pediatrics, July 25, 2023, DOI: 10.1542/peds.2022-060531

GREIF NAMED TO NEWSWEEK'S LIST OF THE TOP 100 GLOBAL MOST LOVED WORKPLACES FOR 2023

Retrieved on: 
Wednesday, May 31, 2023
Workforce, BPI, Comparative effectiveness research, Culture, Workplace, Research, Person, Glassdoor, The Youngest Was the Most Loved, NYSE, Management, Newsweek, Greif

DELAWARE, Ohio, May 31, 2023 /PRNewswire/ -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today the company has been named to Newsweek's list of the Top 100 Global Most Loved Workplaces. The 2023 Global Top 100 Most Loved Workplaces is the newest list in the Most Loved Workplace® collaboration with the Best Practice Institute (BPI), a leadership development and benchmark research company.

Key Points: 
  • DELAWARE, Ohio, May 31, 2023 /PRNewswire/ -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today the company has been named to Newsweek's list of the Top 100 Global Most Loved Workplaces.
  • The 2023 Global Top 100 Most Loved Workplaces is the newest list in the Most Loved Workplace® collaboration with the Best Practice Institute (BPI), a leadership development and benchmark research company.
  • Greif is pleased to be among this esteemed group of global companies for this inaugural list after having been recognized in the Top 100 America's list of Most Loved Workplaces in 2021 and 2022.
  • "We are honored to be distinguished as a Top 100 Global Most Loved Workplace," said Ole Rosgaard, Greif President and Chief Executive Officer.

Weave Wins 3 Cultural Excellence Awards from Top Workplaces USA

Retrieved on: 
Wednesday, April 26, 2023
Technology, Human Resources, Telecommunications, Business, Professional Services, Small Business, Software, Environmental, Social and Governance (ESG), VoIP, Interface (computing), Communication, Multimedia, Environment, Comparative effectiveness research, NYSE, Compensation and benefits, Compensation, Management, Weave

Weave (NYSE: WEAV), the all-in-one customer communication and engagement platform for small- and medium-sized businesses, has received three Cultural Excellence Awards in Innovation, Work-Life Balance, and Compensation & Benefits from Top Workplaces USA.

Key Points: 
  • Weave (NYSE: WEAV), the all-in-one customer communication and engagement platform for small- and medium-sized businesses, has received three Cultural Excellence Awards in Innovation, Work-Life Balance, and Compensation & Benefits from Top Workplaces USA.
  • View the full release here: https://www.businesswire.com/news/home/20230426005003/en/
    The awards, now in their 16th year, recognize companies that go above and beyond to cultivate outstanding workplace cultures.
  • We are honored to win these Cultural Excellence Awards and are committed to fostering an effective and engaged team that lives our core values."
  • Based on employee feedback collected by Energage, Weave ranks in the top 1% of similar-sized companies for work-life balance and flexibility.

Older Patients Shown to Exhibit Better Pain Relief, Quality of Life Than Younger Patients Following Total Knee Arthroplasty

Retrieved on: 
Tuesday, March 7, 2023
TKA, MD, American Academy, Ageing, Life, Massachusetts Department of Public Health, Hospital, Knee, SF-12, Incidence, Quality, Physical therapy, Patient, AAOS, Quality of life, Obesity, Injury, BBC, Surgeon, Health, Function, Literature, Comparative effectiveness research, Arthritis, Athlete, University of Massachusetts Chan Medical School, University, Osteoarthritis, William H. Harris (orthopaedic surgeon), BMI, OA, Smoker, Birth control, Nursing, Dentistry, Pain, Orthopedic surgery

The study, "Age-Related Differences in Pain, Function and Quality of Life Following Primary Total Knee Arthroplasty," analyzed 11,602 patients who underwent a unilateral (one knee) TKA.

Key Points: 
  • The study, "Age-Related Differences in Pain, Function and Quality of Life Following Primary Total Knee Arthroplasty," analyzed 11,602 patients who underwent a unilateral (one knee) TKA.
  • Patients were segmented into cohorts by ages: less than 55, 55-64, 65-74 and 75 years and older.
  • At one year after TKA, younger patients still reported slightly worse pain, function and quality of life, but better function scores than patients older than 75.
  • These data help them know what to expect in terms of pain at one year and set realistic expectations.

Dysgraphia Life Launches a $250,000 Engagement Award Project to Promote Research

Retrieved on: 
Tuesday, February 14, 2023
CER, Thomas Power, Caregiver, Science, Independent Payment Advisory Board, Learning disability, Learning, Dysgraphia, Student, Eugene Washington, PCORI, American Occupational Therapy Association, Comparative effectiveness research, American Occupational Therapy Foundation, Architect, Patient, Hospital, Nameplate capacity, Research, Health, Patient-Centered Outcomes Research Institute, Reading, Parent, Congress, Children's Hospital of Philadelphia, Dyslexia, Johns Hopkins University, Philadelphia, DRS, Nursing

VIENNA, Va., Feb. 14, 2023 /PRNewswire/ -- Dysgraphia Life is launching a new project that was approved for a $250,000 award through the Eugene Washington PCORI Engagement Awards program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). This project, Building Capacity for Patient Centered Outcomes Research in the Dysgraphia Community, will focus on building awareness, engagement, and research capacity for specific learning disability of written expression or dysgraphia.

Key Points: 
  • VIENNA, Va., Feb. 14, 2023 /PRNewswire/ -- Dysgraphia Life is launching a new project that was approved for a $250,000 award through the Eugene Washington PCORI Engagement Awards program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).
  • This project, Building Capacity for Patient Centered Outcomes Research in the Dysgraphia Community, will focus on building awareness, engagement, and research capacity for specific learning disability of written expression or dysgraphia.
  • "We are honored to have been selected by PCORI for funding of this important work," said Dr. Jennifer C. King, Founder and President of Dysgraphia Life.
  • People with dysgraphia need more research and clear evidence on what interventions and management strategies can best help them succeed."

Skin Laundry Recognized in Comparably's "Best Places to Work" Awards: Top 100 Best CEOs of 2022

Retrieved on: 
Thursday, December 29, 2022
Parental leave, San Francisco Bay Area, Laundry, Culture, Growth, The Top 100 Drugs: Clinical Pharmacology and Practical Prescribing, Skin, Multimedia, HQ, Science, Comparative effectiveness research, Thermo-mechanical fatigue, Pharmaceutical industry

LOS ANGELES, Dec. 29, 2022 /PRNewswire/ -- Gregg Throgmartin, CEO of trailblazing Los Angeles-based skincare company Skin Laundry, was named a Top 100 "Best CEOs of 2022" by Comparably's "Best Places to work" awards. Throgmartin, who joined the company in 2018, puts culture and flexibility before all else to support the brand's ambitious growth goals, with a team that is truly invested in the company and its mission.

Key Points: 
  • LOS ANGELES, Dec. 29, 2022 /PRNewswire/ -- Gregg Throgmartin, CEO of trailblazing Los Angeles-based skincare company Skin Laundry, was named a Top 100 "Best CEOs of 2022" by Comparably's "Best Places to work" awards.
  • Under Throgmartin's leadership, Skin Laundry has moved to a membership-first model and is on track to own and operate 100 clinics around the world by 2024.
  • Known for "making laser facials a thing," Skin Laundry has been called "revolutionary" by Forbes, and named one of Fast Company's "Beauty Startups to Watch."
  • Comparably's 6th Annual list of Best CEOs represents the top-ranked chief executives of 2022 based solely on anonymous employee sentiment ratings provided to Comparably.com over the past year.

Parkinson's Foundation Presents Six Studies at MDS International Congress 2022

Retrieved on: 
Thursday, September 15, 2022
Rest, Center, Parkinson's disease, International Congress on Tuberculosis, Alzheimer's disease, Palliative care, Excellent, Comparative effectiveness research, Grammatical mood, Anxiety, Foundation, Dominican Republic, Research, Disease, Death, Clingen, United States Public Health Service, Facial expression, Prevalence, Lists of diseases, Dominican, NEW, Treatment, Person, Genetics, Doctor of Philosophy, Parkinson's Foundation, Principal investigator, Depression, Neurodegeneration, Tremor, FDA, Quality, Instagram, Foundation Center, Genetic testing, Poster, PD, PAB, Precision medicine, Twitter, Neurology, Gene, MS, Quality of life, Standard of care, Hotel manager, Randomized controlled trial, Clinical, CER, Movement, Education, Pharmaceutical industry, MD, Facebook

MIAMI and NEW YORK, Sept. 15, 2022 /PRNewswire/ -- The Parkinson's Foundation will present six scientific posters highlighting research, care and education at the 2022 International Congress of Parkinson's Disease and Movement Disordershosted by the International Parkinson and Movement Disorders Society.

Key Points: 
  • MIAMI and NEW YORK, Sept. 15, 2022 /PRNewswire/ -- The Parkinson's Foundation will present six scientific posters highlighting research, care and education at the 2022 International Congress of Parkinson's Disease and Movement Disordershosted by the International Parkinson and Movement Disorders Society.
  • "We are confident that PD GENEration's contributions to the global research community will bring us closer to scientific breakthroughs.
  • Through PD GENEration, we have developed international collaborations with fieldwide experts, allowing us to accelerate the research and treatment field forward globally."
  • The Parkinson's Foundation makes life better for people with Parkinson's disease by improving care and advancing research toward a cure.

G8 Countries Dog Care Market Report to 2025 - Featuring Mars, Nestle, Royal Canin and Colgate-Palmolive Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, August 12, 2022
Pets, Consumer, Competitive analysis, G8, Comparative effectiveness research, Industry, CAGR, Growth, Animal, Pet, Pharmaceutical industry

The "G8 Countries Dog Care Market Summary, Competitive Analysis and Forecast, 2016-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "G8 Countries Dog Care Market Summary, Competitive Analysis and Forecast, 2016-2025" report has been added to ResearchAndMarkets.com's offering.
  • The G8 Dog Care industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025).
  • What will be the size of the G8 dog care market in 2025?
  • What factors are affecting the strength of competition in the G8 dog care market?

DGAP-News: APONTIS PHARMA rolls out new Single Pill for secondary prophylaxis

Retrieved on: 
Wednesday, July 6, 2022
Patient, Fortis Healthcare, Comparative effectiveness research, Ticker, START, Integrated Blood Pressure Control, Stroke, Goal, Hyperlipidemia, Mortality, Lipid metabolism, Risk, Monheim am Rhein, Tablet, Myocardial infarction, EUR, Degenerative disease, Hypertension, ASA, Physician, Recurrence, Pharmaceutical industry

APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5 ), a leading pharmaceutical company specializing in Single Pills in the German market, is fully on track to achieve its goals.

Key Points: 
  • APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5 ), a leading pharmaceutical company specializing in Single Pills in the German market, is fully on track to achieve its goals.
  • Today, the Single Pill Company announces the rollout of the Single Pill RosuASS in July.
  • With this Single Pill, APONTIS PHARMA addresses the secondary prophylaxis of the group of patients with cardiovascular events in Germany and has thus been able to realize all three targeted market rollouts in financial year 2022.
  • Since 2013, APONTIS successfully launched several Single Pill products alone for cardiovascular indications such as hypertension, hyperlipidemia and secondary prevention.